Subgroup analysis of the phase 3 RECORD-1 trial of everolimus in patients with metastatic renal cell carcinoma: 1 versus 2 prior vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies Meeting Abstract

  

Authors:	Figlin, R. A.; Motzer, R.; Hutson, T. E.; Oudard, S.; Porta, C.; Grünwald, V.; Ravaud, A.; Panneerselvam, A.; Calvo, E.
Abstract Title:	Subgroup analysis of the phase 3 RECORD-1 trial of everolimus in patients with metastatic renal cell carcinoma: 1 versus 2 prior vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies
Meeting Title:	10th International Kidney Cancer Symposium
Journal Title:	BJU International
Volume:	109
Issue:	Suppl.5
Meeting Dates:	2011 Oct 14-15
Meeting Location:	Chicago, IL
ISSN:	1464-4096
Publisher:	Wiley Blackwell
Date Published:	2012-05-01
Start Page:	4
End Page:	5
Language:	English
ACCESSION:	WOS:000303438400010
PROVIDER:	wos
Notes:	--- - Meeting Abstract: 9 - 10th International Kidney Cancer Symposium - OCT 14-15, 2011 - Chicago, IL - "5" - SI - "Source: Wos"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/28978